LH/HCG Receptor Expression and Retrieval Rates

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2007 by Aristotle University Of Thessaloniki.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT00438373
First received: February 21, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

The purpose of this study is to evaluate if there is an association between the serum LH receptor expression on the day of hCG administration or the day of oocyte retrieval and the retrieval rates at oocyte pick up


Condition
Subfertility

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Association of LH/HCG Receptor Expression and Retrieval Rates at Oocyte Pick up.

Further study details as provided by Aristotle University Of Thessaloniki:

Estimated Enrollment: 100
Study Start Date: January 2007
Estimated Study Completion Date: January 2007
Detailed Description:

The purpose of this study is to evaluate if there is an association between the serum LH receptor expression on the day of hCG or the day of oocyte retrieval and the retrieval rates at oocyte pick up.

For this purpose, m-RNA copy numbers will be assessed in the blood serum of patients undergoing ovarian stimulation for IVF on different days.

Furthermore, detailed ultrasound scans will be perfomed, as well as assesment of hormonal levels during ovarian stimulation.

  Eligibility

Ages Eligible for Study:   18 Years to 39 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Age <39 years,
  • Body mass index (BMI) between 18 and 29 kg/m2,
  • Presence of both ovaries,
  • FSH levels <10 IU/l.

Exclusion criteria:

  • Endometriomas,
  • Polycystic ovarian syndrome.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00438373

Contacts
Contact: Efstratios Kolibianakis, MD, PhD 0030 2310 693377 stratis.kolibianakis@irg.gr

Locations
Greece
Unit of Human Reproduction, 1st Department of Obstetrics & Gynecology, AUTH, Papageorgiou Hospital Recruiting
Thessaloniki, Greece, 56429
Contact: Efstratios Kolibianakis, MD    00302310693377      
Principal Investigator: Kaliopi Loutradi         
Sponsors and Collaborators
Aristotle University Of Thessaloniki
Investigators
Study Director: Basil C Tarlatzis, MD, PhD Unit of Human Reproduction, 1st Department of Obs & Gyne, Aristotle University of Thessaloniki, Papageorgiou Hospital, Greece
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00438373     History of Changes
Other Study ID Numbers: UHR-1
Study First Received: February 21, 2007
Last Updated: February 21, 2007
Health Authority: Greece: Ministry of Health and Welfare

Keywords provided by Aristotle University Of Thessaloniki:
Subfertility, Luteinizing hormone, receptor

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female

ClinicalTrials.gov processed this record on July 29, 2014